www.fdanews.com/articles/84645-india-africa-get-free-hiv-drug-license
INDIA, AFRICA GET FREE HIV DRUG LICENSE
February 17, 2006
Bristol Myers-Squibb will license its anti-retroviral drug Reyataz royalty-free
to two drug makers in Africa and India. Generic drug firms Aspen Pharmacare
of South Africa and India's Emcure Pharmaceuticals can produce and sell the
protease inhibitor Reyataz, generically known as atazanavir, in sub-Saharan
Africa, according to the deal announced Wednesday.
United
Press International